Global Blood Glucose Test Strips Market
Global Blood Glucose Test Strips Market Overview:
The global blood glucose test strip market accounted for $9,062 million in 2017 and is expected to reach $15,046 million by 2026, registering a CAGR of 5.7% from 2018 to 2026.
Diabetes is a disorder in which the patient has an elevated blood glucose level caused due to inefficiency of pancreases to produce insulin. Glucose monitoring is one of the essential step towards diabetes management by monitoring the elevated glucose levels in blood. Monitoring of blood glucose provides important data for patients to make daily management decisions such as amount of food intake, insulin dose, and physical exercise. Blood glucose test strip is a medical device that serves the purpose of measuring the glucose level in blood. Blood glucose test strips form the key component of blood glucose monitor device and is used to determine the concentration of glucose in the blood in diabetic patients. Test strips are small, disposable bands/strips of paper or other material, which are usually made from plastic. These strips are infused with different types of enzymes such as glucose oxidase, glucose dehydrogenase, hexokinase, and others. Enzymes present in the strip react with the glucose present in blood, which indicates the glucose level in the blood. Further, the amount of blood required by a test strip to detect blood glucose level may vary among manufacturers. In general, between 0.5 l and 1 l of blood is required to detect the blood glucose level. In addition, most glucose meters are based on the principle of electrochemical technology. They use electrochemical test strips to measure the glucose level using a small drop of blood. Colorimetric and amperometric methods are the two common types of electrochemical measurement of glucose.
Blood glucose test strips market outlook has witnessed a paradigm shift towards technological advancements over the recent years. Upsurge in the population of diabetic patients owing to rapid urbanization and sedentary lifestyle across the globe drives the market growth of blood glucose test strips. Diabetes has been declared as a global epidemic by the World Health Organization (WHO), owing to its high prevalence rate. In addition, in 2004, WHO estimated the diabetic population to increase from 171 million in 2000 to 366 million by 2030. In addition, increase in geriatric population across the globe accelerates the market growth. The risk of diabetes increases with age due to loss of muscle mass, obesity, and lack of exercise. For instance, the prevalence of diabetes in the elderly population is almost one-half of the overall diabetic population due to poor diet, dementia, vision loss, and neuropathies. Further, rise in awareness regarding diabetes management, surge in need for faster and safer diagnosis, has shifted the market trend towards self-monitoring devices. However, stringent reimbursement policies and high cost associated with the regular use of these strips are the major factors that hamper the market growth. Furthermore, blood glucose monitoring devices do not accurately measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. On the contrary, technological advancements in the glucose monitoring devices such as advent of minimally invasive monitoring devices is anticipated to create lucrative opportunities in the near future. Moreover, increase in the investment to develop novel blood glucose test products from government in the developing economies and growing awareness regarding the same in the residents of Asia-Pacific region, especially China, and India, offers profitable blood glucose test strips market insights for the manufacturers exploring untapped economies.
Furthermore, leading manufacturers of blood glucose monitors with the support from government organizations have focused on developing and manufacturing innovative products. These are more portable, inexpensive, reliable and sensitive home-based glucometers that has helped in shaping the market outlook propelling the demand for blood glucose test strips. For instance, DarioHealth Corp., one of the leading digital health companies operating globally with mobile health and big data solutions, announced the approval of the lightning-enabled version of the acclaimed Dario blood glucose monitoring system by the USFDA, which enables the use of the Dario app on iPhone 7, 8, and X smart mobile devices (SMD). Recent developments include introduction of mobile devices for self-monitoring of blood glucose that are integrated with smartphone app that shows test results. For instance, Roche Diabetes Care India, subsidiary of F. Hoffmann-La Roche Ltd., launched new glucometer Accu- Chek Instant S in India on February 2018. This glucometer offers accurate self-monitoring blood glucose and meets the latest global ISO 15197:2013 standards, at an affordable price.
The blood glucose test strips market is categorized into technology, electrode type, and end users. Based on technology, it is classified into glucose oxidase and glucose dehydrogenase. Based on electrode type, it is classified as thick film, thin film, and optical film. Based on end user, it is classified as hospitals, home settings, and diagnostic centers. Based on region, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global blood glucose test strips market include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, F. Hoffmann-La Roche Ltd., Medtronic plc, Johnson & Johnson (LifeScan), Dexcom, Inc., B. Braun Holding GmbH & Co. KG, Nipro Diagnostics, Universal Biosensors Inc., and Apex Biotechnology Corp.
KEY TAKEAWAYS
MARKET LANDSCAPE
By Technology
The global blood glucose test strip market accounted for $9,062 million in 2017 and is expected to reach $15,046 million by 2026, registering a CAGR of 5.7% from 2018 to 2026.
Diabetes is a disorder in which the patient has an elevated blood glucose level caused due to inefficiency of pancreases to produce insulin. Glucose monitoring is one of the essential step towards diabetes management by monitoring the elevated glucose levels in blood. Monitoring of blood glucose provides important data for patients to make daily management decisions such as amount of food intake, insulin dose, and physical exercise. Blood glucose test strip is a medical device that serves the purpose of measuring the glucose level in blood. Blood glucose test strips form the key component of blood glucose monitor device and is used to determine the concentration of glucose in the blood in diabetic patients. Test strips are small, disposable bands/strips of paper or other material, which are usually made from plastic. These strips are infused with different types of enzymes such as glucose oxidase, glucose dehydrogenase, hexokinase, and others. Enzymes present in the strip react with the glucose present in blood, which indicates the glucose level in the blood. Further, the amount of blood required by a test strip to detect blood glucose level may vary among manufacturers. In general, between 0.5 l and 1 l of blood is required to detect the blood glucose level. In addition, most glucose meters are based on the principle of electrochemical technology. They use electrochemical test strips to measure the glucose level using a small drop of blood. Colorimetric and amperometric methods are the two common types of electrochemical measurement of glucose.
Blood glucose test strips market outlook has witnessed a paradigm shift towards technological advancements over the recent years. Upsurge in the population of diabetic patients owing to rapid urbanization and sedentary lifestyle across the globe drives the market growth of blood glucose test strips. Diabetes has been declared as a global epidemic by the World Health Organization (WHO), owing to its high prevalence rate. In addition, in 2004, WHO estimated the diabetic population to increase from 171 million in 2000 to 366 million by 2030. In addition, increase in geriatric population across the globe accelerates the market growth. The risk of diabetes increases with age due to loss of muscle mass, obesity, and lack of exercise. For instance, the prevalence of diabetes in the elderly population is almost one-half of the overall diabetic population due to poor diet, dementia, vision loss, and neuropathies. Further, rise in awareness regarding diabetes management, surge in need for faster and safer diagnosis, has shifted the market trend towards self-monitoring devices. However, stringent reimbursement policies and high cost associated with the regular use of these strips are the major factors that hamper the market growth. Furthermore, blood glucose monitoring devices do not accurately measure the exact level of glucose in blood and give a range in which the blood glucose level of a patient may lie. On the contrary, technological advancements in the glucose monitoring devices such as advent of minimally invasive monitoring devices is anticipated to create lucrative opportunities in the near future. Moreover, increase in the investment to develop novel blood glucose test products from government in the developing economies and growing awareness regarding the same in the residents of Asia-Pacific region, especially China, and India, offers profitable blood glucose test strips market insights for the manufacturers exploring untapped economies.
Furthermore, leading manufacturers of blood glucose monitors with the support from government organizations have focused on developing and manufacturing innovative products. These are more portable, inexpensive, reliable and sensitive home-based glucometers that has helped in shaping the market outlook propelling the demand for blood glucose test strips. For instance, DarioHealth Corp., one of the leading digital health companies operating globally with mobile health and big data solutions, announced the approval of the lightning-enabled version of the acclaimed Dario blood glucose monitoring system by the USFDA, which enables the use of the Dario app on iPhone 7, 8, and X smart mobile devices (SMD). Recent developments include introduction of mobile devices for self-monitoring of blood glucose that are integrated with smartphone app that shows test results. For instance, Roche Diabetes Care India, subsidiary of F. Hoffmann-La Roche Ltd., launched new glucometer Accu- Chek Instant S in India on February 2018. This glucometer offers accurate self-monitoring blood glucose and meets the latest global ISO 15197:2013 standards, at an affordable price.
The blood glucose test strips market is categorized into technology, electrode type, and end users. Based on technology, it is classified into glucose oxidase and glucose dehydrogenase. Based on electrode type, it is classified as thick film, thin film, and optical film. Based on end user, it is classified as hospitals, home settings, and diagnostic centers. Based on region, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.
The major players operating in the global blood glucose test strips market include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, F. Hoffmann-La Roche Ltd., Medtronic plc, Johnson & Johnson (LifeScan), Dexcom, Inc., B. Braun Holding GmbH & Co. KG, Nipro Diagnostics, Universal Biosensors Inc., and Apex Biotechnology Corp.
KEY TAKEAWAYS
MARKET LANDSCAPE
By Technology
- Glucose Oxidase
- Glucose Dehydrogenase
- Thin Film
- Thick Film
- Optical Film
- Hospital
- Diagnostic Centers
- Homecare
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- china
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
SECTION 1 EXECUTIVE SUMMARY
1.1. KEY FINDINGS
1.2. MARKET ATTRACTIVENESS AND TREND ANALYSIS
1.3. COMPETITIVE LANDSCAPE AND RECENT INDUSTRY DEVELOPMENT ANALYSIS
SECTION 2 INTRODUCTION
2.1. REPORT DESCRIPTION
2.2. SCOPE AND DEFINITIONS
2.3. RESEARCH METHODOLOGY
SECTION 3 MARKET LANDSCAPE
3.1. GROWTH DRIVERS
3.1.1. Impact Analysis
3.2. RESTRAINS AND CHALLENGES
3.2.1. Impact Analysis
3.3. PORTERS ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SHARES ANALYSIS, 2015-2026
3.4.1. Global blood glucose test strips market share by technology, 2015-2026
3.4.2. Global blood glucose test strips market share by electrode type, 2015-2026
3.4.3. Global blood glucose test strips market share by end user, 2015-2026
3.4.4. Global blood glucose test strips market share by geography, 2015-2026
SECTION 4 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY TECHNOLOGY
4.1. GLUCOSE DEHYDROGENASE
4.1.1. Historical Market Size by Region, 2015-2017
4.1.2. Market Forecast by Region, 2018-2026
4.2. GLUCOSE OXIDASE
4.2.1. Historical Market Size by Region, 2015-2017
4.2.2. Market Forecast by Region, 2018-2026
SECTION 5 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY ELECTRODE TECHNOLOGY
5.1. THICK FILM
5.1.1. Historical Market Size by Region, 2015-2017
5.1.2. Market Forecast by Region, 2018-2026
5.2. THIN FILM
5.2.1. Historical Market Size by Region, 2015-2017
5.2.2. Market Forecast by Region, 2018-2026
5.3. OPTICAL FILM
5.3.1. Historical Market Size by Region, 2015-2017
5.3.2. Market Forecast by Region, 2018-2026
SECTION 6 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY END USER
6.1. HOSPITALS
6.1.1. Historical Market Size by Region, 2015-2017
6.1.2. Market Forecast by Region, 2018-2026
6.2. HOMECARE SETTINGS
6.2.1. Historical Market Size by Region, 2015-2017
6.2.2. Market Forecast by Region, 2018-2026
6.3. RESEARCH INSTITUTES
6.3.1. Historical Market Size by Region, 2015-2017
6.3.2. Market Forecast by Region, 2018-2026
SECTION 7 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY GEOGRAPHY
7.1. NORTH AMERICA
7.1.1. U.S.
7.1.1.1. Historical Market Size, 2015-2017
7.1.1.2. Market Forecast, 2018-2026
7.1.2. Mexico
7.1.2.1. Historical Market Size, 2015-2017
7.1.2.2. Market Forecast, 2018-2026
7.1.3. Canada
7.1.3.1. Historical Market Size, 2015-2017
7.1.3.2. Market Forecast, 2018-2026
7.2. EUROPE
7.2.1. Germany
7.2.1.1. Historical Market Size, 2015-2026
7.2.1.2. Market Forecast, 2018-2026
7.2.2. France
7.2.2.1. Historical Market Size, 2015-2017
7.2.2.2. Market Forecast, 2018-2026
7.2.3. UK
7.2.3.1. Historical Market Size, 2015-2017
7.2.3.2. Market Forecast, 2018-2026
7.2.4. Italy
7.2.4.1. Historical Market Size, 2015-2017
7.2.4.2. Market Forecast, 2018-2026
7.2.5. Spain
7.2.5.1. Historical Market Size, 2015-2017
7.2.5.2. Market Forecast, 2018-2026
7.2.7. Rest of Europe
7.2.7.1. Historical Market Size, 2015-2017
7.2.7.2. Market Forecast, 2018-2026
7.3. ASIA PACIFIC
7.3.1. Japan
7.3.1.1. Historical Market Size, 2015-2017
7.3.1.2. Market Forecast, 2018-2026
7.3.2. China
7.3.2.1. Historical Market Size, 2015-2017
7.3.2.2. Market Forecast, 2018-2026
7.3.3. India
7.3.3.1. Historical Market Size, 2015-2017
7.3.3.2. Market Forecast, 2018-2026
7.3.4. Australia
7.3.4.1. Historical Market Size, 2015-2017
7.3.4.2. Market Forecast, 2018-2026
7.3.5. South Korea
7.3.5.1. Historical Market Size, 2015-2017
7.3.5.2. Market Forecast, 2018-2026
7.3.6. Rest of Asia Pacific
7.3.6.1. Historical Market Size, 2015-2017
7.3.6.2. Market Forecast, 2018-2026
7.4. LAMEA
7.4.1. Brazil
7.4.1.1. Historical Market Size, 2015-2017
7.4.1.2. Market Forecast, 2018-2026
7.4.4. Saudi Arabia
7.4.4.1. Historical Market Size, 2015-2017
7.4.4.2. Market Forecast, 2018-2026
7.4.5. South Africa
7.4.5.1. Historical Market Size, 2015-2017
7.4.5.2. Market Forecast, 2018-2026
7.4.6. Rest of LAMEA
7.4.6.1. Historical Market Size, 2015-2017
7.4.6.2. Market Forecast, 2018-2026
SECTION 8 COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Overview
8.1.2. Financials and business segments
8.1.3. Recent Developments
8.2. ASCENSIA DIABETES CARE HOLDINGS AG
8.2.1. Overview
8.2.2. Financials and business segments
8.2.3. Recent Developments
8.3. F. Hoffmann-La Roche Ltd.
8.3.1. Overview
8.3.2. Financials and business segments
8.3.3. Recent Developments
8.4. MEDTRONIC PLC
8.4.1. Overview
8.4.2. Financials and business segments
8.4.3. Recent Developments
8.5. JOHNSON & JOHNSON (LIFESCAN)
8.5.1. Overview
8.5.2. Financials and business segments
8.5.3. Recent Developments
8.6. DEXCOM, INC.
8.6.1. Overview
8.6.2. Financials and business segments
8.6.3. Recent Developments
8.7. B. BRAUN HOLDING GMBH & CO. KG
8.7.1. Overview
8.7.2. Financials and business segments
8.7.3. Recent Developments
8.8. NIPRO DIAGNOSTICS
8.8.1. Overview
8.8.2. Financials and business segments
8.8.3. Recent Developments
8.9. UNIVERSAL BIOSENSORS INC.
8.9.1. Overview
8.9.2. Financials and business segments
8.9.3. Recent Developments
8.10. APEX BIOTECHNOLOGY CORP
8.10.1. Overview
8.10.2. Financials and business segments
8.10.3. Recent Developments
1.1. KEY FINDINGS
1.2. MARKET ATTRACTIVENESS AND TREND ANALYSIS
1.3. COMPETITIVE LANDSCAPE AND RECENT INDUSTRY DEVELOPMENT ANALYSIS
SECTION 2 INTRODUCTION
2.1. REPORT DESCRIPTION
2.2. SCOPE AND DEFINITIONS
2.3. RESEARCH METHODOLOGY
SECTION 3 MARKET LANDSCAPE
3.1. GROWTH DRIVERS
3.1.1. Impact Analysis
3.2. RESTRAINS AND CHALLENGES
3.2.1. Impact Analysis
3.3. PORTERS ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET SHARES ANALYSIS, 2015-2026
3.4.1. Global blood glucose test strips market share by technology, 2015-2026
3.4.2. Global blood glucose test strips market share by electrode type, 2015-2026
3.4.3. Global blood glucose test strips market share by end user, 2015-2026
3.4.4. Global blood glucose test strips market share by geography, 2015-2026
SECTION 4 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY TECHNOLOGY
4.1. GLUCOSE DEHYDROGENASE
4.1.1. Historical Market Size by Region, 2015-2017
4.1.2. Market Forecast by Region, 2018-2026
4.2. GLUCOSE OXIDASE
4.2.1. Historical Market Size by Region, 2015-2017
4.2.2. Market Forecast by Region, 2018-2026
SECTION 5 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY ELECTRODE TECHNOLOGY
5.1. THICK FILM
5.1.1. Historical Market Size by Region, 2015-2017
5.1.2. Market Forecast by Region, 2018-2026
5.2. THIN FILM
5.2.1. Historical Market Size by Region, 2015-2017
5.2.2. Market Forecast by Region, 2018-2026
5.3. OPTICAL FILM
5.3.1. Historical Market Size by Region, 2015-2017
5.3.2. Market Forecast by Region, 2018-2026
SECTION 6 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY END USER
6.1. HOSPITALS
6.1.1. Historical Market Size by Region, 2015-2017
6.1.2. Market Forecast by Region, 2018-2026
6.2. HOMECARE SETTINGS
6.2.1. Historical Market Size by Region, 2015-2017
6.2.2. Market Forecast by Region, 2018-2026
6.3. RESEARCH INSTITUTES
6.3.1. Historical Market Size by Region, 2015-2017
6.3.2. Market Forecast by Region, 2018-2026
SECTION 7 GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET BY GEOGRAPHY
7.1. NORTH AMERICA
7.1.1. U.S.
7.1.1.1. Historical Market Size, 2015-2017
7.1.1.2. Market Forecast, 2018-2026
7.1.2. Mexico
7.1.2.1. Historical Market Size, 2015-2017
7.1.2.2. Market Forecast, 2018-2026
7.1.3. Canada
7.1.3.1. Historical Market Size, 2015-2017
7.1.3.2. Market Forecast, 2018-2026
7.2. EUROPE
7.2.1. Germany
7.2.1.1. Historical Market Size, 2015-2026
7.2.1.2. Market Forecast, 2018-2026
7.2.2. France
7.2.2.1. Historical Market Size, 2015-2017
7.2.2.2. Market Forecast, 2018-2026
7.2.3. UK
7.2.3.1. Historical Market Size, 2015-2017
7.2.3.2. Market Forecast, 2018-2026
7.2.4. Italy
7.2.4.1. Historical Market Size, 2015-2017
7.2.4.2. Market Forecast, 2018-2026
7.2.5. Spain
7.2.5.1. Historical Market Size, 2015-2017
7.2.5.2. Market Forecast, 2018-2026
7.2.7. Rest of Europe
7.2.7.1. Historical Market Size, 2015-2017
7.2.7.2. Market Forecast, 2018-2026
7.3. ASIA PACIFIC
7.3.1. Japan
7.3.1.1. Historical Market Size, 2015-2017
7.3.1.2. Market Forecast, 2018-2026
7.3.2. China
7.3.2.1. Historical Market Size, 2015-2017
7.3.2.2. Market Forecast, 2018-2026
7.3.3. India
7.3.3.1. Historical Market Size, 2015-2017
7.3.3.2. Market Forecast, 2018-2026
7.3.4. Australia
7.3.4.1. Historical Market Size, 2015-2017
7.3.4.2. Market Forecast, 2018-2026
7.3.5. South Korea
7.3.5.1. Historical Market Size, 2015-2017
7.3.5.2. Market Forecast, 2018-2026
7.3.6. Rest of Asia Pacific
7.3.6.1. Historical Market Size, 2015-2017
7.3.6.2. Market Forecast, 2018-2026
7.4. LAMEA
7.4.1. Brazil
7.4.1.1. Historical Market Size, 2015-2017
7.4.1.2. Market Forecast, 2018-2026
7.4.4. Saudi Arabia
7.4.4.1. Historical Market Size, 2015-2017
7.4.4.2. Market Forecast, 2018-2026
7.4.5. South Africa
7.4.5.1. Historical Market Size, 2015-2017
7.4.5.2. Market Forecast, 2018-2026
7.4.6. Rest of LAMEA
7.4.6.1. Historical Market Size, 2015-2017
7.4.6.2. Market Forecast, 2018-2026
SECTION 8 COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Overview
8.1.2. Financials and business segments
8.1.3. Recent Developments
8.2. ASCENSIA DIABETES CARE HOLDINGS AG
8.2.1. Overview
8.2.2. Financials and business segments
8.2.3. Recent Developments
8.3. F. Hoffmann-La Roche Ltd.
8.3.1. Overview
8.3.2. Financials and business segments
8.3.3. Recent Developments
8.4. MEDTRONIC PLC
8.4.1. Overview
8.4.2. Financials and business segments
8.4.3. Recent Developments
8.5. JOHNSON & JOHNSON (LIFESCAN)
8.5.1. Overview
8.5.2. Financials and business segments
8.5.3. Recent Developments
8.6. DEXCOM, INC.
8.6.1. Overview
8.6.2. Financials and business segments
8.6.3. Recent Developments
8.7. B. BRAUN HOLDING GMBH & CO. KG
8.7.1. Overview
8.7.2. Financials and business segments
8.7.3. Recent Developments
8.8. NIPRO DIAGNOSTICS
8.8.1. Overview
8.8.2. Financials and business segments
8.8.3. Recent Developments
8.9. UNIVERSAL BIOSENSORS INC.
8.9.1. Overview
8.9.2. Financials and business segments
8.9.3. Recent Developments
8.10. APEX BIOTECHNOLOGY CORP
8.10.1. Overview
8.10.2. Financials and business segments
8.10.3. Recent Developments
LIST OF TABLES
TABLE 1. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR TECHNOLOGY, BY REGION, 2015-2026, $MILLION
TABLE 2. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ELECTRODE TYPE, BY REGION, 2015-2026, $MILLION
TABLE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR END USER, BY REGION, 2015-2026, $MILLION
TABLE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR HOSPITALS, BY REGION, 2015-2026, $MILLION
TABLE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR HOMECARE SETTINGS, BY REGION, 2015-2026, $MILLION
TABLE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR RESEARCH INSTITUTES, BY REGION, 2015-2026, $MILLION
TABLE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY COUNTRY, 2015-2026, $MILLION
TABLE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY END USER, 2015-2026, $MILLION
TABLE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY COUNTRY, 2015-2026, $MILLION
TABLE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 14. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY END USER, 2015-2026, $MILLION
TABLE 15. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY COUNTRY, 2015-2026, $MILLION
TABLE 16. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 17. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 18. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY END USER, 2015-2026, $MILLION
TABLE 19. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY COUNTRY, 2015-2026, $MILLION
TABLE 20. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 21. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 22. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY END USER, 2015-2026, $MILLION
TABLE 23. ABBOTT LABORATORIES - COMPANY SNAPSHOT
TABLE 24. ASCENSIA DIABETES CARE HOLDINGS AG - COMPANY SNAPSHOT
TABLE 25. F. HOFFMANN-LA ROCHE LTD. - COMPANY SNAPSHOT
TABLE 26. MEDTRONIC PLC - COMPANY SNAPSHOT
TABLE 27. JOHNSON & JOHNSON (LIFESCAN) - COMPANY SNAPSHOT
TABLE 28. DEXCOM, INC - COMPANY SNAPSHOT
TABLE 29. B. BRAUN HOLDING GMBH & CO. KG - COMPANY SNAPSHOT
TABLE 30. NIPRO DIAGNOSTICS. - COMPANY SNAPSHOT
TABLE 31. UNIVERSAL BIOSENSORS INC. - COMPANY SNAPSHOT
TABLE 32. APEX BIOTECHNOLOGY CORP.- COMPANY SNAPSHOT
TABLE 1. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR TECHNOLOGY, BY REGION, 2015-2026, $MILLION
TABLE 2. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ELECTRODE TYPE, BY REGION, 2015-2026, $MILLION
TABLE 3. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR END USER, BY REGION, 2015-2026, $MILLION
TABLE 4. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR HOSPITALS, BY REGION, 2015-2026, $MILLION
TABLE 5. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR HOMECARE SETTINGS, BY REGION, 2015-2026, $MILLION
TABLE 6. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR RESEARCH INSTITUTES, BY REGION, 2015-2026, $MILLION
TABLE 7. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY COUNTRY, 2015-2026, $MILLION
TABLE 8. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 9. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 10. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR NORTH AMERICA, BY END USER, 2015-2026, $MILLION
TABLE 11. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY COUNTRY, 2015-2026, $MILLION
TABLE 12. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 13. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 14. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR EUROPE, BY END USER, 2015-2026, $MILLION
TABLE 15. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY COUNTRY, 2015-2026, $MILLION
TABLE 16. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 17. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 18. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR ASIA PACIFIC, BY END USER, 2015-2026, $MILLION
TABLE 19. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY COUNTRY, 2015-2026, $MILLION
TABLE 20. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY TECHNOLOGY, 2015-2026, $MILLION
TABLE 21. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY ELECTRODE TYPE, 2015-2026, $MILLION
TABLE 22. GLOBAL BLOOD GLUCOSE TEST STRIPS MARKET VALUE FOR REST OF THE WORLD, BY END USER, 2015-2026, $MILLION
TABLE 23. ABBOTT LABORATORIES - COMPANY SNAPSHOT
TABLE 24. ASCENSIA DIABETES CARE HOLDINGS AG - COMPANY SNAPSHOT
TABLE 25. F. HOFFMANN-LA ROCHE LTD. - COMPANY SNAPSHOT
TABLE 26. MEDTRONIC PLC - COMPANY SNAPSHOT
TABLE 27. JOHNSON & JOHNSON (LIFESCAN) - COMPANY SNAPSHOT
TABLE 28. DEXCOM, INC - COMPANY SNAPSHOT
TABLE 29. B. BRAUN HOLDING GMBH & CO. KG - COMPANY SNAPSHOT
TABLE 30. NIPRO DIAGNOSTICS. - COMPANY SNAPSHOT
TABLE 31. UNIVERSAL BIOSENSORS INC. - COMPANY SNAPSHOT
TABLE 32. APEX BIOTECHNOLOGY CORP.- COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. GLOBAL BLOOD GLUCOSE TEST STRIP: HOSPITALS MARKET VALUE, 2015-2026, $MILLION
FIGURE 2. GLOBAL BLOOD GLUCOSE TEST STRIP: HOMECARE SETTINGS MARKET VALUE, 2015-2026, $MILLION
FIGURE 3. GLOBAL BLOOD GLUCOSE TEST STRIP: RESEARCH INSTITUTES MARKET VALUE, 2015-2026, $MILLION
FIGURE 4. GLOBAL BLOOD GLUCOSE TEST STRIP: NORTH AMERICA MARKET VALUE, 2015-2026, $MILLION
FIGURE 5. GLOBAL BLOOD GLUCOSE TEST STRIP: U.S. MARKET VALUE, 2015-2026, $MILLION
FIGURE 6. GLOBAL BLOOD GLUCOSE TEST STRIP: MEXICO MARKET VALUE, 2015-2026, $MILLION
FIGURE 7. GLOBAL BLOOD GLUCOSE TEST STRIP: CANDA MARKET VALUE, 2015-2026, $MILLION
FIGURE 8. GLOBAL BLOOD GLUCOSE TEST STRIP: EUROPE MARKET VALUE, 2015-2026, $MILLION
FIGURE 9. GLOBAL BLOOD GLUCOSE TEST STRIP: GERMANY MARKET VALUE, 2015-2026, $MILLION
FIGURE 10.GLOBAL BLOOD GLUCOSE TEST STRIP: FRANCE MARKET VALUE, 2015-2026, $MILLION
FIGURE 11.GLOBAL BLOOD GLUCOSE TEST STRIP: UK MARKET VALUE, 2015-2026, $MILLION
FIGURE 12.GLOBAL BLOOD GLUCOSE TEST STRIP: ITALY MARKET VALUE, 2015-2026, $MILLION
FIGURE 13.GLOBAL BLOOD GLUCOSE TEST STRIP: SPAIN MARKET VALUE, 2015-2026, $MILLION
FIGURE 15.GLOBAL BLOOD GLUCOSE TEST STRIP: ASIA PACIFIC MARKET VALUE, 2015-2026, $MILLION
FIGURE 16.GLOBAL BLOOD GLUCOSE TEST STRIP: JAPAN MARKET VALUE, 2015-2026, $MILLION
FIGURE 17.GLOBAL BLOOD GLUCOSE TEST STRIP: CHINA MARKET VALUE, 2015-2026, $MILLION
FIGURE 18.GLOBAL BLOOD GLUCOSE TEST STRIP: INDIA MARKET VALUE, 2015-2026, $MILLION
FIGURE 19.GLOBAL BLOOD GLUCOSE TEST STRIP: AUSTRALIA MARKET VALUE, 2015-2026, $MILLION
FIGURE 20.GLOBAL BLOOD GLUCOSE TEST STRIP: SOUTH KOREA MARKET VALUE, 2015-2026, $MILLION
FIGURE 21.GLOBAL BLOOD GLUCOSE TEST STRIP: REST OF ASIA PACIFIC MARKET VALUE, 2015-2026, $MILLION
FIGURE 22.GLOBAL BLOOD GLUCOSE TEST STRIP: LAMEA MARKET VALUE, 2015-2026, $MILLION
FIGURE 23.GLOBAL BLOOD GLUCOSE TEST STRIP: BRAZIL MARKET VALUE, 2015-2026, $MILLION
FIGURE 26.GLOBAL BLOOD GLUCOSE TEST STRIP: SAUDI ARABIA MARKET VALUE, 2015-2026, $MILLION
FIGURE 27.GLOBAL BLOOD GLUCOSE TEST STRIP: SOUTH AFRICA MARKET VALUE, 2015-2026, $MILLION
FIGURE 28.GLOBAL BLOOD GLUCOSE TEST STRIP: REST OF LAMEA MARKET VALUE, 2015-2026, $MILLION
FIGURE 1. GLOBAL BLOOD GLUCOSE TEST STRIP: HOSPITALS MARKET VALUE, 2015-2026, $MILLION
FIGURE 2. GLOBAL BLOOD GLUCOSE TEST STRIP: HOMECARE SETTINGS MARKET VALUE, 2015-2026, $MILLION
FIGURE 3. GLOBAL BLOOD GLUCOSE TEST STRIP: RESEARCH INSTITUTES MARKET VALUE, 2015-2026, $MILLION
FIGURE 4. GLOBAL BLOOD GLUCOSE TEST STRIP: NORTH AMERICA MARKET VALUE, 2015-2026, $MILLION
FIGURE 5. GLOBAL BLOOD GLUCOSE TEST STRIP: U.S. MARKET VALUE, 2015-2026, $MILLION
FIGURE 6. GLOBAL BLOOD GLUCOSE TEST STRIP: MEXICO MARKET VALUE, 2015-2026, $MILLION
FIGURE 7. GLOBAL BLOOD GLUCOSE TEST STRIP: CANDA MARKET VALUE, 2015-2026, $MILLION
FIGURE 8. GLOBAL BLOOD GLUCOSE TEST STRIP: EUROPE MARKET VALUE, 2015-2026, $MILLION
FIGURE 9. GLOBAL BLOOD GLUCOSE TEST STRIP: GERMANY MARKET VALUE, 2015-2026, $MILLION
FIGURE 10.GLOBAL BLOOD GLUCOSE TEST STRIP: FRANCE MARKET VALUE, 2015-2026, $MILLION
FIGURE 11.GLOBAL BLOOD GLUCOSE TEST STRIP: UK MARKET VALUE, 2015-2026, $MILLION
FIGURE 12.GLOBAL BLOOD GLUCOSE TEST STRIP: ITALY MARKET VALUE, 2015-2026, $MILLION
FIGURE 13.GLOBAL BLOOD GLUCOSE TEST STRIP: SPAIN MARKET VALUE, 2015-2026, $MILLION
FIGURE 15.GLOBAL BLOOD GLUCOSE TEST STRIP: ASIA PACIFIC MARKET VALUE, 2015-2026, $MILLION
FIGURE 16.GLOBAL BLOOD GLUCOSE TEST STRIP: JAPAN MARKET VALUE, 2015-2026, $MILLION
FIGURE 17.GLOBAL BLOOD GLUCOSE TEST STRIP: CHINA MARKET VALUE, 2015-2026, $MILLION
FIGURE 18.GLOBAL BLOOD GLUCOSE TEST STRIP: INDIA MARKET VALUE, 2015-2026, $MILLION
FIGURE 19.GLOBAL BLOOD GLUCOSE TEST STRIP: AUSTRALIA MARKET VALUE, 2015-2026, $MILLION
FIGURE 20.GLOBAL BLOOD GLUCOSE TEST STRIP: SOUTH KOREA MARKET VALUE, 2015-2026, $MILLION
FIGURE 21.GLOBAL BLOOD GLUCOSE TEST STRIP: REST OF ASIA PACIFIC MARKET VALUE, 2015-2026, $MILLION
FIGURE 22.GLOBAL BLOOD GLUCOSE TEST STRIP: LAMEA MARKET VALUE, 2015-2026, $MILLION
FIGURE 23.GLOBAL BLOOD GLUCOSE TEST STRIP: BRAZIL MARKET VALUE, 2015-2026, $MILLION
FIGURE 26.GLOBAL BLOOD GLUCOSE TEST STRIP: SAUDI ARABIA MARKET VALUE, 2015-2026, $MILLION
FIGURE 27.GLOBAL BLOOD GLUCOSE TEST STRIP: SOUTH AFRICA MARKET VALUE, 2015-2026, $MILLION
FIGURE 28.GLOBAL BLOOD GLUCOSE TEST STRIP: REST OF LAMEA MARKET VALUE, 2015-2026, $MILLION
